⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for enzalutamide 40 mg

Every month we try and update this database with for enzalutamide 40 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC StageNCT05627752
Prostate Cancer
Castrate Resist...
Enzalutamide 40...
Docetaxel injec...
18 Years - 75 YearsZhongnan Hospital
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III StudyNCT03464201
Ovarian Cancer
Enzalutamide 40...
18 Years - Grupo Español de Tumores Huérfanos e Infrecuentes
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III StudyNCT03464201
Ovarian Cancer
Enzalutamide 40...
18 Years - Grupo Español de Tumores Huérfanos e Infrecuentes
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: